论文信息 - Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. - 字舞流文

Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC.

J. Chin | A. Zardan | A. Feifer | V. Fradet | D. Drachenberg | B. Shayegan | R. Sabbagh | H. Hew | R. Rendon | G. Gotto | R. Plante | B. Danielson | Katherine F Y Chan | R. Casey | F. Camacho | Anousheh Zardan